The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Open accessAbstract
Translational research and precision medicine are based on a profound knowledge of cellular and molecular mechanisms contributing to various physiologic processes and pathologic reactions in diverse organs. Whereas specific molecular interactions and mechanisms have been identified during the past 5 decades, the underlying principles were defined much earlier and originate from to the seminal observations made by outstanding researchers between 1850 and 1915. One of the most outstanding exponents of these scientists is Paul Ehrlich. His work resulted not only in the foundation and birth of modern hematology and immunology, but also led to the development of chemotherapy and specific targeted treatment concepts. In 2015, the Medical University of Vienna organized a memorial meeting, with the aim of honoring Paul Ehrlich's contributions to science, and to commemorate the 100th anniversary of his death. The authors of the current review served as faculty members and dedicate this paper to Paul Ehrlich and his remarkable contributions to medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beiträge zur Kenntniss der Anilinfärbungen und ihrer Verwendung in der mikroskopischen Technik
Ehrlich, P. (1877) · Archiv für Mikroskopische Anatomie · doi:10.1007/bf02933937 · Cited by 334
Sneader, W. (2005) · Cited by 302
Bosch, F., & Rosich, L. (2008) · Pharmacology · doi:10.1159/000149583 · Cited by 292
Kaufmann, S. H. E. (2008) · Nature Immunology · doi:10.1038/ni0708-705 · Cited by 292
The Composition of Ehrlich's Salvarsan: Resolution of a Century‐Old Debate
Lloyd, N. C., Morgan, H. W., Nicholson, B. K., & Ronimus, R. S. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461471 · Cited by 256
Schwartz, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048021 · Cited by 221
Paul Ehrlich — in search of the magic bullet
Winau, F., Westphal, O., & Winau, R. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.04.003 · Cited by 164
A History of the Use of Arsenicals in Man
Jolliffe, D. (1993) · Journal of the Royal Society of Medicine · doi:10.1177/014107689308600515 · Cited by 118
Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells
Enrico Crivellato, B., Beltrami, C. A., Mallardi, F., & Ribatti, D. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04573.x · Cited by 110
Paul Ehrlich: founder of chemotherapy
Kaufmann, S. H. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2582 · Cited by 104
Antibodies and gene therapy: teaching old ‘magic bullets’ new tricks
Sanz, L., Blanco, B., & Álvarez‐Vallina, L. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.12.001 · Cited by 91
Rubin, R. P. (2007) · Pharmacological Reviews · doi:10.1124/pr.107.70102 · Cited by 89
The contributions of Paul Ehrlich to infectious disease
Gensini, G. F., Conti, A. A., & Lippi, D. (2006) · Journal of Infection · doi:10.1016/j.jinf.2004.05.022 · Cited by 82
The concept of transmitter receptors: 100 years on
Bennett, M. R. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00137-9 · Cited by 69
Newsome, B. W., & Ernstoff, M. S. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03187.x · Cited by 63
Case histories, magic bullets and the state of drug discovery
Drews, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2084 · Cited by 45
Kasten, F. H. (1996) · Biotechnic & Histochemistry · doi:10.3109/10520299609117128 · Cited by 45
Kristiansen, J. E. (1989) · PubMed · Cited by 45
Drews, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1498 · Cited by 44
Cited by
Probiotics, prebiotics and synbiotics- a review
Pandey, K. R., Naik, S. R., & Vakil, B. V. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1921-1 · Cited by 1,291
Current state of melanoma diagnosis and treatment
Davis, L. E., Shalin, S. C., & Tackett, A. J. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1640032 · Cited by 922
Demystifying theory and its use in improvement
Davidoff, F., Dixon-Woods, M., Leviton, L., & Michie, S. (2015) · BMJ Quality & Safety · doi:10.1136/bmjqs-2014-003627 · Cited by 714
Neutralizing monoclonal antibodies for treatment of COVID-19
Taylor, P. C., Adams, A. C., Hufford, M. M., de la Torre, I., Winthrop, K., & Gottlieb, R. L. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00542-x · Cited by 732
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
Hoelder, S., Clarke, P. A., & Workman, P. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.02.004 · Cited by 587
Metadata
- Authors
- Valent, P., Groner, B., Schumacher, U., Superti-Furga, G., Busslinger, M., Kralovics, R., Zielinski, C., Penninger, J. M., Kerjaschki, D., Stingl, G., Smolen, J. S., Valenta, R., Lassmann, H., Kovar, H., Jäger, U., Kornek, G., Müller, M., & Sörgel, F.
- Venue
- Journal of Innate Immunity
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 8
- Issue
- 2
- Pages
- 111-120
- ISSN
- 1662-811X (ISSN-L)
- 1662-8128
- OpenAlex
- W2256634634
- Cited by
- 409
- References
- 19
- FWCI
- 24.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.